Fresenius Historical Income Statement
FMS Stock | USD 19.28 0.08 0.41% |
Historical analysis of Fresenius Medical income statement accounts such as Gross Profit of 3.7 B or Operating Income of 1.4 B can show how well Fresenius Medical Care performed in making a profits. Evaluating Fresenius Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fresenius Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Fresenius Medical Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fresenius Medical Care is a good buy for the upcoming year.
Fresenius |
About Fresenius Income Statement Analysis
Fresenius Medical Care Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fresenius Medical shareholders. The income statement also shows Fresenius investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Fresenius Medical Income Statement Chart
Fresenius Medical Care Income Statement is one of the three primary financial statements used for reporting Fresenius's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Fresenius Medical Care revenue and expense. Fresenius Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Fresenius Medical's Net Income is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 357.8 M in 2024, whereas Total Revenue is likely to drop slightly above 11.4 B in 2024. Add Fundamental
Total Revenue
Total revenue comprises all receipts Fresenius Medical Care generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Fresenius Medical Care minus its cost of goods sold. It is profit before Fresenius Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Fresenius Medical Care financial statement analysis. It represents the amount of money remaining after all of Fresenius Medical Care operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Fresenius Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At this time, Fresenius Medical's Net Income is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 357.8 M in 2024, whereas Total Revenue is likely to drop slightly above 11.4 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.1B | 5.3B | 4.9B | 3.7B | Total Revenue | 17.6B | 19.4B | 19.5B | 11.4B |
Fresenius Medical income statement Correlations
Click cells to compare fundamentals
Fresenius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fresenius Medical income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 491M | 410M | 353M | 360M | 336M | 234.9M | |
Total Revenue | 17.5B | 17.9B | 17.6B | 19.4B | 19.5B | 11.4B | |
Gross Profit | 5.4B | 5.5B | 5.1B | 5.3B | 4.9B | 3.7B | |
Operating Income | 710M | 529M | 301.3M | (258.4M) | 1.5B | 1.4B | |
Ebit | 710M | 529M | 301.3M | (258.4M) | 1.7B | 1.4B | |
Ebitda | 2.3B | 2.3B | 1.9B | 1.6B | 3.4B | 2.1B | |
Net Income | 1.2B | 1.2B | 969.3M | 673.4M | 499.0M | 712.5M | |
Income Tax Expense | 402M | 501M | 353M | 325M | 301M | 357.8M | |
Depreciation And Amortization | 1.6B | 1.8B | 1.6B | 1.8B | 1.8B | 1.8B | |
Selling General Administrative | 3.1B | 3.2B | 3.1B | 3.8B | 3.2B | 3.0B | |
Other Operating Expenses | 15.3B | 15.7B | 15.9B | 18.1B | 18.0B | 10.2B | |
Research Development | 168M | 194M | 221M | 229M | 232M | 243.6M | |
Cost Of Revenue | 12.1B | 12.3B | 12.5B | 14.1B | 14.5B | 8.0B | |
Total Operating Expenses | 3.2B | 3.4B | 3.3B | 4.0B | 3.4B | 2.2B | |
Income Before Tax | 1.8B | 1.9B | 1.6B | 1.2B | 911M | 1.2B | |
Total Other Income Expense Net | 1.1B | 1.4B | 1.3B | 1.5B | (586M) | (556.7M) | |
Net Income Applicable To Common Shares | 1.2B | 1.2B | 969.3M | 673.4M | 774.4M | 931.7M | |
Minority Interest | 1.3B | 1.1B | (250M) | (222M) | (233.5M) | (221.8M) | |
Net Income From Continuing Ops | 1.4B | 1.4B | 1.2B | 895M | 732.5M | 1.1B | |
Tax Provision | 401.6M | 501M | 353M | 325M | 300.6M | 357.8M | |
Interest Income | 429.4M | 368M | 280M | 68M | 88.2M | 83.8M | |
Net Interest Income | (429.4M) | (368.0M) | (280M) | (292M) | (336.4M) | (353.2M) | |
Reconciled Depreciation | 1.6B | 1.8B | 1.6B | 1.8B | 1.8B | 1.6B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Fresenius Stock analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Fresenius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.353 | Dividend Share 1.19 | Earnings Share 0.92 | Revenue Per Share 33.1505 | Quarterly Revenue Growth (0) |
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.